Raphael Pharmaceutical Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
31 December
Raphael Pharmaceutical Inc. has filed 176 SEC EDGAR filings since 24 Oct 2007

SEC filing history

Showing 26-50 of 105 matching filings.

Per page
25
Current page
2
8-K File 000-53002

CURRENT REPORT

Filing date
26 Jun 2024
Reporting date
26 Jun 2024
Next action
Verify source filing
DEF 14C File 000-53002

INFORMATION STATEMENT

Filing date
04 Jun 2024
Reporting date
04 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-53002

INFORMATION STATEMENT

Filing date
23 May 2024
Reporting date
23 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
10-K File 000-53002

ANNUAL REPORT

Filing date
28 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2024
Reporting date
25 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2024
Reporting date
29 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
09 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
EFFECT File 333-265878

EFFECT filing

Filing date
13 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260766

EFFECT filing

Filing date
13 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-265878

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
01 Jun 2023
Reporting date
Not listed
Next action
Verify source filing
POS AM File 333-260766

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
01 Jun 2023
Reporting date
Not listed
Next action
Verify source filing
10-K/A File 000-53002

AMENDMENT NO. 1 TO FORM 10-K

Filing date
25 May 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
15 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
POS AM File 333-260766

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
04 May 2023
Reporting date
Not listed
Next action
Verify source filing
POS AM File 333-265878

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
02 May 2023
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-53002

CURRENT REPORT

Filing date
28 Mar 2023
Reporting date
27 Mar 2023
Next action
Verify source filing
10-K File 000-53002

ANNUAL REPORT

Filing date
24 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
4

4 filing

Filing date
13 Mar 2023
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Mar 2023
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Mar 2023
Reporting date
26 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Mar 2023
Reporting date
05 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Mar 2023
Reporting date
26 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .